10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q 

(Mark One)

☒     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ____________ to ____________

Commission file number: 000-56332

Hawkeye Systems, Inc.

(Exact name of small business issuer as specified in its charter)

Nevada	83-0799093
(State or other jurisdiction  of incorporation or organization)	(IRS Employer Identification No.)

6605 Abercorn, Suite 204

Savannah, GA 31405

(Address of principal executive offices)

(912) 253-0375

(Registrants telephone number, including area code)

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act

Title of Each Class	Trading Symbol(s)	Name of each Exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes     ☒ No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☐ Yes     ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer	☒	Smaller reporting company
		☒	Non-accelerated filer	☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes     ☒ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes     ☒ No

The number of shares outstanding of each of the issuer’s classes of common equity as of October 26, 2021, was 19,329,148 shares of common stock.

Contents

		Page
Part 1	FINANCIAL INFORMATION
Item 1	Financial Statements (unaudited)	3
	Condensed Consolidated Balance Sheets as of September 30, 2021 and June 30, 2021 (unaudited)	3
	Condensed Consolidated Statements of Operations for the three months ended September 30, 2021 and 2020 (unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended  September 30, 2021 and 2020 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2021 and 2020 (unaudited)	6
	Notes to the Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 4.	Controls and Procedures	13
Part II.	OTHER INFORMATION
Item 1	Legal Proceedings	15
Item 1A	Risk Factors	15
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3	Defaults Upon Senior Securities	15
Item 4	Mine Safety Disclosures	15
Item 5	Other Information	15
Item 6	Exhibits	16
	SIGNATURES	17

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	September 30,			June 30,
	2021			2021
ASSETS
Current assets:
Cash	$	97,085		$	282,131
Prepaid expenses		13,000			3,000
Total current assets		110,085			285,131
Total assets	$	110,085		$	285,131
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	135,963		$	133,088
Convertible note payable, net of discount - related party		480,373			450,933
Inventory financing payable - related party		500,000			500,000
Common stock payable - related party		477,000			477,000
Total current liabilities		1,593,336			1,561,021
Long-term liabilities:
PPP loan		16,983			16,983
Total liabilities		1,610,319			1,578,004
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 18,221,148 and 17,921,148 shares issued and outstanding, respectively		1,822			1,792
Additional paid-in capital		8,060,973			7,957,009
Common stock to be issued - 0 and 425,000 shares, respectively		-			-
Accumulated deficit		(9,563,029	)		(9,251,674	)
Total stockholders’ deficit		(1,500,234	)		(1,292,873	)
Total liabilities and stockholders’ deficit	$	110,085		$	285,131

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended
	September 30,
	2021			2020
Sales	$	-		$	382,346
Cost of sales		-			320,379
Gross profit		-			61,967
Operating expenses:
General and administrative		22,889			13,797
Management compensation		171,299			153,662
Professional fees		26,270			38,024
Professional fees - related party		38,498			139,340
Marketing		-			48,418
Write-down of inventory		-			40,164
Total operating expenses		258,956			433,405
Loss from operations		(258,956	)		(371,438	)
Other expense:
Interest expense		2,041			(26,833	)
Interest expense - related party		(54,440	)		(12,899	)
Financing expense		-			(55,497	)
Financing expense - related party		-			(1,508,211	)
Loss on settlement of debt		-			(370,269	)
Total other expense		(52,399	)		(1,973,709	)
Net loss	$	(311,355	)	$	(2,345,147	)
Net loss per common share - basic and diluted	$	(0.02	)	$	(0.15	)
Weighted average common shares outstanding - basic and diluted		17,943,978			15,562,663

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

For the Three Months Ended September 30, 2021

					Additional		Common
	Common Stock				Paid-in		Stock		Accumulated			Stockholders’
	Shares		Amount		Capital		to be Issued		Deficit			Deficit
Balance, June 30, 2021		17,921,148	$	1,792	$	7,957,009	$	-	$	(9,251,674	)	$	(1,292,873	)
Common stock issued for settlement of debt		300,000		30		29,970		-		-			30,000
Stock based compensation – options		-		-		73,994		-		-			73,994
Net loss		-		-		-		-		(311,355	)		(311,355	)
Balance, September 30, 2021		18,221,148	$	1,822	$	8,060,973	$	-	$	(9,563,029	)	$	(1,500,234	)

For the Three Months Ended September 30, 2020

							Common
					Additional		Stock
	Common Stock				Paid-in		to be			Accumulated			Stockholders’
	Shares		Amount		Capital		Issued			Deficit			Equity
Balance, June 30, 2020		14,828,036	$	1,483	$	4,527,925	$	139,500		$	(4,509,841	)	$	159,067
Common shares issued for stock to be issued		365,000		37		109,463		(109,500	)		-			-
Warrants exercised for cash		175,000		17		67,483		-			-			67,500
Common shares issued for conversion of debt		469,623		47		525,931		-			-			525,978
Stock based compensation – options		-		-		119,155		-			-			119,155
Stock based compensation – warrant		-		-		1,563,708		-			-			1,563,708
Debt forgiveness		-		-		20,932		-			-			20,932
Net loss		-		-		-		-			(2,345,147	)		(2,345,147	)
Balance, September 30, 2020		15,837,659	$	1,584	$	6,934,597	$	30,000		$	(6,854,988	)	$	111,193

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended
	September 30,
	2021			2020
Cash flows from operating activities:
Net loss	$	(311,355	)	$	(2,345,147	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		-			602
Write-down of inventory		-			40,164
Loss on settlement of debt		-			370,269
Amortization of debt discount		29,440			25,274
Stock based compensation – options and warrant		73,994			1,682,863
Change in operating assets and liabilities:
Accounts receivable		-			(1,815	)
Inventory		-			(901,713	)
Prepaid expense		(10,000	)		(13,212	)
Accounts payable and accrued liabilities		32,875			211,724
Common stock payable		-			3,000
Net cash used in operating activities		(185,046	)		(927,991	)
Cash flows from financing activities:
Proceeds from exercise of warrants		-			67,500
Net cash provided by financing activities		-			67,500
Net change in cash		(185,046	)		(860,491	)
Cash beginning of period		282,131			911,747
Cash end of period	$	97,085		$	51,256
Supplemental cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash investing and financing activities:
Common stock issued on conversion of note payable	$	-		$	525,978
Common stock issued for settlement of debt	$	30,000		$	-
Reclassification from note payable related party to stock payable	$	-		$	200,000
Reclassification from common stock to be issued to common stock	$	-		$	109,500
Debt forgiveness	$	-		$	20,932

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

Note 1 – Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (“the Company”), a Nevada corporation incorporated on May 15, 2018, is a technology holding company evaluating strategic alternatives.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2021, as filed with the SEC on October 13, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

7

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2021 and 2020, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2021		2020
Warrants		2,563,996		8,939,131
Options		7,280,000		5,255,000
Convertible notes		2,000,000		1,000,000
Total possible dilutive shares		11,843,996		15,194,131

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

Note 2 – Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three months ended September 30, 2021, the Company had a net loss of $311,355. As of September 30, 2021, the Company had an accumulated deficit of $9,563,029. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3 – Convertible Notes Payable

Convertible notes – related party

On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The original maturity date of the note was April 6, 2021.  The note has been extended for 12 months under the same terms and the new maturity date is April 6, 2022. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.

8

On December 15, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on December 15, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.

During the three months ended September 30, 2021 and 2020, amortization of $29,440 and $25,274, respectively ,was recognized as interest expense. As of September 30, 2021 and June 30, 2021, the balance of the notes payable is $500,000 less unamortized debt discount of $19,627 and $49,067, to net $480,373 and $450,933, respectively. Interest expense of $22,917 and $1,958 respectively, was recognized on the convertible notes during the three months ended September 30, 2021 and 2020.

Note 4 – Common stock payable – related party

As of September 30, 2021 and June 30, 2021, the Company reported common stock payable of $477,000, which represents 1,908,000 shares to be issued. Subsequent to September 30, 2021 all of these shares were issued.

Note 5 – Stockholders’ Equity

Common Stock

During the three months ended September 30, 2021, the Company had the following common stock transactions:

· 300,000 shares issued valued at $30,000 for settlement of debt of $30,000.

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended September 30, 2021 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		3,069,329			2.27
Granted		-			-
Exercised – shares issued		-			-
Expired		(505,333	)		0.83
Balance at September 30, 2021		2,563,996		$	2.71

The composition of the Company’s warrants outstanding at September 30, 2021 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.20		100,000		1.43
$	0.30		349,998		2.84
$	0.50		666,666		2.84
$	1.00		708,666		2.84
$	1.50		20,000		0.25
$	2.00		718,666		2.66
			2,563,996		2.71

At September 30, 2021, the intrinsic value of the 2,563,996 outstanding warrant was $0.

9

Stock Options

Transactions in stock options for the three months ended September 30, 2021 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2021		7,280,000		0.23		3.76
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2021		7,280,000		0.23		3.50
Exercisable, September 30, 2021		6,170,000	$	0.24		3.30

During the three months ended September 30, 2021, $73,994 was expensed, of which $29,997 was to related parties, and as of September 30, 2021, $167,992 remains unamortized, of which $79,995 is with related parties.

At September 30, 2021, the intrinsic value of the 7,280,000 outstanding options was $0.

Note 6 – Commitments and Contingencies

On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. During the three months ended September 30, 2021, the Company issued 300,000 shares of common stock at $0.10 per share to settle accounts payable of $30,000. As of September 30, 2021 and June 30, 2021, the Company had a balance of $0 and $30,000 in accounts payable, respectively.

On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the three months ended September 30, 2021, compensation expense of $62,500 was recognized under this agreement. The agreement contained provisions for severance, health benefits, and a car allowance.

Note 7 – Subsequent Events

Subsequent to September 30, 2021, the Company issued 1,108,000 shares for stock payable of $277,000.

Subsequent to September 30, 2021, the Company issued a letter of intent to acquire Six 15 Technologies, a technology company that designs, develops, and manufactures head-up displays (HUDs) for enterprise and defense users. The transaction being negotiated is an all-share transaction that will result in the acquirer holding a majority of the shares in the Company.

10

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the three months ended September 30, 2021.

Forward-Looking Statements

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this Annual Report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Annual Report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Annual Report.

Financial Condition and Results of Operations

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Results of Operations

Three Months Ended September 30, 2021

We had operating revenues of $0 in our three months ended September 30, 2021. Cost of sales was $0 resulting in gross profit (loss) of $0.

Total operating expenses in the three months ended September 30, 2021 were $258,956 compared to $433,405 for the same period in 2020. The decrease in operating expenses is primarily a result of decreased write down of inventory, professional fees – related party and marketing expense offset by an increase in management compensation and general administrative expense. The Company’s net loss was $311,355 for the three months ended September 30, 2021 compared to $2,345,147 for the three months ended September 30, 2020. The net loss for this period is primarily a result of operating expenses, and interest expense.

Three Months Ended September 30, 2020

We had operating revenues of $382,346 in our three months ended June 30, 2020. Cost of sales was $320,379 resulting in gross profit of $61,967, or 16%. These revenues are from the sale of PPE products.

Liquidity and Capital Resources

Our cash balance at September 30, 2021 was $97,085 compared to $282,131 at June 30, 2021. We do not believe these cash reserves are sufficient to cover our expenses for our operations for fiscal year ending June 30, 2022. We will require additional funding for our ongoing operations. While we have a loan payable from Radiant Systems of $1,305,800 and interest due from Radiant of $154,042, those amounts are reflected impaired on our balance sheet as a result of the litigation with Radiant. Nevertheless, we intend to vigorously pursue that litigation and expect to recover those amounts.

11

In addition, we intend to raise funds through the sale of equity and the exercise of warrants issued in private placements. Although to date we have had some warrant exercises for cash, there can be no assurance that we will be able to raise money through this offering or through the exercise of warrants. If we cannot raise any additional financing prior to the expiration of the first quarter of 2022, we believe we will be able to obtain loans from management in the future, if necessary, but have no agreement in writing.

We are an emerging growth company and have limited revenue to date. Under a limited operations scenario to maintain our corporate existence, we believe we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation through private placements, warrant exercises or alternative financings to implement our complete business plan.

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near term. We have no guarantees or firm commitments that the related party advances will continue in the near term.

Existing working capital, further advances, together with anticipated capital raises and anticipated cash flow are expected to be adequate to fund our operations over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through proceeds from the sale of our common stock, warrant exercises and convertible loans.

Management anticipates additional increases in operating expenses relating to: (i) developmental expenses; and (ii) marketing expenses. We intend to finance these expenses with issuances of securities and through the exercise of outstanding warrants.

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

Material Commitments

As of the date of this Current Report, we do not have any material commitments.

Purchase of Significant Equipment

We do not intend to purchase any significant equipment during the next twelve months.

Off-Balance Sheet Arrangements

As of the date of this Current Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

12

Going Concern

As reflected in the accompanying financial statements, the Company had an accumulated deficit of $9,563,029 at September 30, 2021 and net loss from operations of $258,956.

The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of equity securities and related party advances. In addition, the Company is in the development stage and has generated limited revenues since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The ability of the Company to continue operations is dependent on the success of Management’s plans and raising of capital through the issuance of equity securities, until such time that funds provided by operations are sufficient to fund working capital requirements.

The Company will require additional funding to finance the growth of its current and expected future operations as well as to achieve its strategic objectives. The Company believes its current available cash may be insufficient to meet its cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 8.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Annual Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. In our review, we sought to find potential for material weaknesses in our financial controls, which is defined as a deficiency, or combination of deficiencies, in our accounting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatement, whether unintentional errors or fraud. s. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

Our management, consisting of Corby Marshall as Chief Executive Officer and Acting Chief Financial Officer, reviewed and evaluated the effectiveness of the Company’s internal control over disclosure controls and procedures (as such term is defined in Rules 13a-15(3) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) , as of December 31, 2020. In making this assessment, our management used the criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as well as the guidance provided in SEC Release 33-8809. In such evaluation, Mr. Marshall assessed daily interaction, self-assessment and other on going monitoring activities as evidence in the evaluation. Furthermore we sought to identify financial reporting risks, identify controls that adequately address financial reporting risks, considered entity level controls, reviewed the role of technology in our controls and reviewed the evidence available to support the assessment.

13

Based on this evaluation, our management concluded that, as of September 30, 2021, our disclosure controls and our internal controls over financial reporting were not effective in recording, processing, summarizing and report on a time basis information required to be disclosed in the reports that we file or submit under the Exchange Act and were not effective in assuring that information required to be disclosed in the reports we file or submit under the Exchange Act due to material weaknesses including (i) the Company having a sole officer and director handling all financial transactions, (ii) lack of appropriate operational controls and consistency in providing our accounting personnel with financial information, (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system, (iv) lack of proper documentation of our assessment and evaluation, and (v) our determination that internal controls were ineffective due to the limited segregation of duties because of the limited management structure.

In response to that assessment we have made a determination that all accounting and financial reporting services should be outsourced to a qualified consulting firm and we immediately engaged a new financial services provider. We subsequently replaced that provider with an internal accounting contractor.

We have also made the determination that we need to dedicate more of the company’s current and future financial resources to this function and have recently engaged a permanent Chief Financial Officer.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permits us to provide only management’s report in this annual report.

Changes in Internal Control over Financial Reporting. Other than engaging a new financial services firm to provide financial statements, there were no changes in our internal control over financial reporting that occurred during the first quarter of the year ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

14

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

On November 13, 2019, 5W Public Relations LLC filed a complaint against Hawkeye Systems, Inc. relating to payments allegedly due under a contract for public relations services. Hawkeye vigorously disputes the allegations in the complaint as 5W Public Relations provided virtually no services to Hawkeye during the term of this arrangement but was paid a substantial amount of funds. Hawkeye has engaged counsel to defend the litigation and also assert counterclaims for failure of consideration, fraud in the inducement, general fraud and other causes of action. Hawkeye anticipates that this litigation if pursued will be resolved favorably for the Company.

Hawkeye has engaged counsel and intends to bring legal action against Radiant Images, Inc. as well as its two principals, Michael Mansouri and Gianna Wolfe, for numerous causes of action including fraud, fraudulent inducement, unjust enrichment and numerous other matters in connection with our agreement with them. We are currently working to replevin shares of stock issued to them and to recover funds payable pursuant to a promissory note due to us from Radiant.

We are not aware of any other legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our properties.

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings or claims, other than those disclosed above, are pending against or involve the Company that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

Item 1A – Risk Factors

Not required for Smaller Reporting Companies.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

Effective September 24, 2021 the Company issued 300,000 shares issued valued at $30,000 for settlement of debt of $30,000.

Item 3 – Defaults Upon Senior Securities

No disclosure required.

Item 4 – Mine Safety Disclosure

No disclosure required.

Item 5 – Other Information

No disclosure required.

15

Item 6 - Exhibits

Exhibits:

Number	Description
31.1*	Certification of Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
31.2*	Certification of Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*	Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.
104*	Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101. DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

___________ 

*     Filed herewith.

**    Furnished herewith.

16

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hawkeye Systems, Inc.
Date: November 15, 2021	By:	/s/ Corby Marshall
		Corby Marshall, Chief Executive Officer
		Principal Executive Officer
Date: November 15, 2021	By:	/s/ Christopher Mulgrew
		Christopher Mulgrew, Chief Financial Officer
		Principal Financial Officer

17

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Corby Marshall, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Hawkeye Systems, Inc. (the "Registrant");
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 15, 2021	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Christopher Mulgrew, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Hawkeye Systems, Inc. (the "Registrant");
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 15, 2021	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Corby Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: November 15, 2021	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Christopher Mulgrew, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: November 15, 2021	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	3 Months Ended
	Sep. 30, 2021	Oct. 26, 2021
Cover [Abstract]
Entity Registrant Name	Hawkeye Systems, Inc.
Entity Central Index Key	0001750777
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	No
Document Period End Date	Sep. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Ex Transition Period	true
Entity Common Stock Shares Outstanding		19,329,148
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56332
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	83-0799093
Entity Address Address Line 1	6605 Abercorn
Entity Address Address Line 2	Suite 204
Entity Address City Or Town	Savannah
Entity Address State Or Province	GA
Entity Address Postal Zip Code	31405
City Area Code	912
Local Phone Number	253-0375
Entity Interactive Data Current	No

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Current assets:
Cash	$ 97,085	$ 282,131
Prepaid expenses	13,000	3,000
Total current assets	110,085	285,131
Total assets	110,085	285,131
Current liabilities:
Accounts payable and accrued liabilities	135,963	133,088
Convertible note payable, net of discount - related party	480,373	450,933
Inventory financing payable - related party	500,000	500,000
Common stock payable - related party	477,000	477,000
Total current liabilities	1,593,336	1,561,021
Long-term liabilities:
PPP loan	16,983	16,983
Total liabilities	1,610,319	1,578,004
Stockholders' deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 18,221,148 and 17,921,148 shares issued and outstanding, respectively	1,822	1,792
Additional paid-in capital	8,060,973	7,957,009
Common stock to be issued - 0 and 425,000 shares, respectively	0	0
Accumulated deficit	(9,563,029)	(9,251,674)
Total stockholders' deficit	(1,500,234)	(1,292,873)
Total liabilities and stockholders' deficit	$ 110,085	$ 285,131

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Jun. 30, 2021
Stockholder's Equity
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	18,221,148	17,921,148
Common stock, shares outstanding	18,221,148	17,921,148
Common stock to be issued shares	0	425,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Sales	$ 0	$ 382,346
Cost of sales	0	320,379
Gross profit	0	61,967
Operating expenses:
General and administrative	22,889	13,797
Management compensation	171,299	153,662
Professional fees	26,270	38,024
Professional fees - related party	38,498	139,340
Marketing	0	48,418
Write-down of inventory	0	40,164
Total operating expenses	258,956	433,405
Loss from operations	(258,956)	(371,438)
Other expense:
Interest expenses	2,041	(26,833)
Interest expense - related party	(54,440)	(12,899)
Financing expense	0	(55,497)
Financing expense - related party	0	(1,508,211)
Loss on settlement of debt	0	(370,269)
Total other expense	(52,399)	(1,973,709)
Net loss	$ (311,355)	$ (2,345,147)
Net loss per common share - basic and diluted	$ (0.02)	$ (0.15)
Weighted average common shares outstanding - basic and diluted	17,943,978	15,562,663

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Common Stock To Be Issued [Member]	Accumulated Deficit [Member]
Balance, shares at Jun. 30, 2020		14,828,036
Balance, amount at Jun. 30, 2020	$ 159,067	$ 1,483	$ 4,527,925	$ 139,500	$ (4,509,841)
Common shares issued for stock to be issued, shares		365,000
Common shares issued for stock to be issued, amount	0	$ 37	109,463	(109,500)	0
Warrants exercised for cash, shares		175,000
Warrants exercised for cash, amount	67,500	$ 17	67,483	0	0
Common shares issued for conversion of debt, shares		469,623
Common shares issued for conversion of debt, amount	525,978	$ 47	525,931
Stock based compensation - options	119,155		119,155
Stock based compensation - warrant	1,563,708		1,563,708
Debt forgiveness	20,932		20,932
Net loss	(2,345,147)				(2,345,147)
Balance, shares at Sep. 30, 2020		15,837,659
Balance, amount at Sep. 30, 2020	111,193	$ 1,584	6,934,597	30,000	(6,854,988)
Balance, shares at Jun. 30, 2021		17,921,148
Balance, amount at Jun. 30, 2021	(1,292,873)	$ 1,792	7,957,009	0	(9,251,674)
Stock based compensation - options	73,994	$ 0	73,994
Net loss	$ (311,355)				(311,355)
Common stock issued for settlement of debt, shares	30,000	300,000
Common stock issued for settlement of debt, amount	$ 30,000	$ 30	29,970	0	0
Balance, shares at Sep. 30, 2021		18,221,148
Balance, amount at Sep. 30, 2021	$ (1,500,234)	$ 1,822	$ 8,060,973	$ 0	$ (9,563,029)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (311,355)	$ (2,345,147)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	0	602
Write-down of inventory	0	40,164
Loss on settlement of debt	0	370,269
Amortization of debt discount	29,440	25,274
Stock based compensation - options and warrant	73,994	1,682,863
Change in operating assets and liabilities:
Accounts receivable	0	(1,815)
Inventory	0	(901,713)
Prepaid expense	(10,000)	(13,212)
Accounts payable and accrued liabilities	32,875	211,724
Common stock payable	0	3,000
Net cash used in operating activities	(185,046)	(927,991)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	67,500
Net cash provided by financing activities	0	67,500
Net change in cash	(185,046)	(860,491)
Cash beginning of period	282,131	911,747
Cash end of period	97,085	51,256
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Common stock issued on conversion of note payable	$ 0	525,978
Common stock issued for settlement of debt	30,000
Reclassification from note payable related party to stock payable	$ 0	200,000
Reclassification from common stock to be issued to common stock	0	109,500
Debt forgiveness	$ 0	$ 20,932

XML

Summary of Significant Accounting Policies

3 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Note 1 - Summary of Significant Accounting Policies

Note 1 – Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (“the Company”), a Nevada corporation incorporated on May 15, 2018, is a technology holding company evaluating strategic alternatives.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2021, as filed with the SEC on October 13, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2021 and 2020, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2021		2020
Warrants		2,563,996		8,939,131
Options		7,280,000		5,255,000
Convertible notes		2,000,000		1,000,000
Total possible dilutive shares		11,843,996		15,194,131

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML

Going Concern

3 Months Ended

Sep. 30, 2021

Going Concern

Note 2 - Going Concern

Note 2 – Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three months ended September 30, 2021, the Company had a net loss of $311,355. As of September 30, 2021, the Company had an accumulated deficit of $9,563,029. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Convertible Notes Payable

3 Months Ended

Sep. 30, 2021

Convertible Notes Payable

Note 3 - Convertible Notes Payable

Note 3 – Convertible Notes Payable

Convertible notes – related party

On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The original maturity date of the note was April 6, 2021.  The note has been extended for 12 months under the same terms and the new maturity date is April 6, 2022. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.

On December 15, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on December 15, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.

During the three months ended September 30, 2021 and 2020, amortization of $29,440 and $25,274, respectively ,was recognized as interest expense. As of September 30, 2021 and June 30, 2021, the balance of the notes payable is $500,000 less unamortized debt discount of $19,627 and $49,067, to net $480,373 and $450,933, respectively. Interest expense of $22,917 and $1,958 respectively, was recognized on the convertible notes during the three months ended September 30, 2021 and 2020.

XML

Common stock payable - related party

3 Months Ended

Sep. 30, 2021

Common stock payable - related party

Note 4 - Common stock payable - related party

Note 4 – Common stock payable – related party

As of September 30, 2021 and June 30, 2021, the Company reported common stock payable of $477,000, which represents 1,908,000 shares to be issued. Subsequent to September 30, 2021 all of these shares were issued.

XML

Stockholders Equity

3 Months Ended

Sep. 30, 2021

Stockholders Equity

Note 5 - Stockholders' Equity

Note 5 – Stockholders’ Equity

Common Stock

During the three months ended September 30, 2021, the Company had the following common stock transactions:

· 300,000 shares issued valued at $30,000 for settlement of debt of $30,000.

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended September 30, 2021 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		3,069,329			2.27
Granted		-			-
Exercised – shares issued		-			-
Expired		(505,333	)		0.83
Balance at September 30, 2021		2,563,996		$	2.71

The composition of the Company’s warrants outstanding at September 30, 2021 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.20		100,000		1.43
$	0.30		349,998		2.84
$	0.50		666,666		2.84
$	1.00		708,666		2.84
$	1.50		20,000		0.25
$	2.00		718,666		2.66
			2,563,996		2.71

At September 30, 2021, the intrinsic value of the 2,563,996 outstanding warrant was $0.

Stock Options

Transactions in stock options for the three months ended September 30, 2021 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2021		7,280,000		0.23		3.76
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2021		7,280,000		0.23		3.50
Exercisable, September 30, 2021		6,170,000	$	0.24		3.30

During the three months ended September 30, 2021, $73,994 was expensed, of which $29,997 was to related parties, and as of September 30, 2021, $167,992 remains unamortized, of which $79,995 is with related parties.

At September 30, 2021, the intrinsic value of the 7,280,000 outstanding options was $0.

XML

Commitments and Contingencies

3 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Note 6 - Commitments and Contingencies

Note 6 – Commitments and Contingencies

On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. During the three months ended September 30, 2021, the Company issued 300,000 shares of common stock at $0.10 per share to settle accounts payable of $30,000. As of September 30, 2021 and June 30, 2021, the Company had a balance of $0 and $30,000 in accounts payable, respectively.

On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the three months ended September 30, 2021, compensation expense of $62,500 was recognized under this agreement. The agreement contained provisions for severance, health benefits, and a car allowance.

XML

Subsequent Events

3 Months Ended

Sep. 30, 2021

Subsequent Events

Note 7 - Subsequent Events

Note 7 – Subsequent Events

Subsequent to September 30, 2021, the Company issued 1,108,000 shares for stock payable of $277,000.

Subsequent to September 30, 2021, the Company issued a letter of intent to acquire Six 15 Technologies, a technology company that designs, develops, and manufactures head-up displays (HUDs) for enterprise and defense users. The transaction being negotiated is an all-share transaction that will result in the acquirer holding a majority of the shares in the Company.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (“the Company”), a Nevada corporation incorporated on May 15, 2018, is a technology holding company evaluating strategic alternatives.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2021, as filed with the SEC on October 13, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2021 and 2020, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2021		2020
Warrants		2,563,996		8,939,131
Options		7,280,000		5,255,000
Convertible notes		2,000,000		1,000,000
Total possible dilutive shares		11,843,996		15,194,131

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Schedule Of Basic and Diluted Earnings Per Share

	September 30,		September 30,
	2021		2020
Warrants		2,563,996		8,939,131
Options		7,280,000		5,255,000
Convertible notes		2,000,000		1,000,000
Total possible dilutive shares		11,843,996		15,194,131

XML

Stockholders Equity (Tables)

3 Months Ended

Sep. 30, 2021

Stockholders Equity

Transactions in stock purchase warrants

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2021		3,069,329			2.27
Granted		-			-
Exercised – shares issued		-			-
Expired		(505,333	)		0.83
Balance at September 30, 2021		2,563,996		$	2.71

Schedule of warrants outstanding

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.20		100,000		1.43
$	0.30		349,998		2.84
$	0.50		666,666		2.84
$	1.00		708,666		2.84
$	1.50		20,000		0.25
$	2.00		718,666		2.66
			2,563,996		2.71

Schedule Of Transactions in stock options

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2021		7,280,000		0.23		3.76
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2021		7,280,000		0.23		3.50
Exercisable, September 30, 2021		6,170,000	$	0.24		3.30

XML

Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Total possible dilutive shares	11,843,996	15,194,131
Convertible Note [Member]
Total possible dilutive shares	2,000,000	1,000,000
Options [Member]
Total possible dilutive shares	7,280,000	5,255,000
Warrant [Member]
Total possible dilutive shares	2,563,996	8,939,131

XML

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021
Going Concern
Accumulated deficit	$ (9,563,029)	$ (9,251,674)
Net loss	$ (311,355)

XML

Convertible Notes Payable (Details Narrative) - USD ($)			3 Months Ended
	Dec. 15, 2020	Apr. 06, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
Amortization of interest expense			$ 29,440	$ 25,274
Unamortized debt discount			19,627		$ 49,067
Notes payable, balance			500,000
Notes payable descriptions	On December 15, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on December 15, 2021	On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The original maturity date of the note was April 6, 2021
Interest expense			$ 22,917	$ 1,958
Conversion price	$ 0.25	$ 0.25
Net proceeds of the fees	$ 250,000
Note issued		$ 250,000
Lender [Member]
Beneficial conversion feature	117,760	51,594
Fair value of options	46,380	$ 13,297
Consideration amount	$ 100,000
Stock option exercisable		100,000
Exercisable price	$ 0.25	$ 0.25

XML

Common stock payable - related party (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2021
Common stock payable - related party
Common shares issued	1,908,000
Common stock payable		$ 477,000

XML

Stockholders Equity (Details) - Warrant [Member]	3 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares
Warrant Shares
Warrants shares, beginnig balance | shares	3,069,329
Warrant shares, expired | $	$ (505,333)
Warrants shares, ending balance | shares	2,563,996
Weighted Average Exercise Price
Weighted average exercise price, beginning	$ 2.27
Weighted average exercise price, Granted	0
Weighted average exercise price, Exercised	0
Weighted average exercise price, Expired	0.83
Weighted average exercise price, Ending	$ 2.71

XML

Stockholders Equity (Details 1)	3 Months Ended
	Sep. 30, 2021 $ / shares shares
Number of Warrants	2,563,996
Weighted Average Remaining Life (in years)	2 years 8 months 15 days
Warrants outsanding 5 [Member]
Number of Warrants	718,666
Weighted Average Remaining Life (in years)	2 years 7 months 28 days
Exercise Price | $ / shares	$ 2.00
Warrants outsanding 4 [Member]
Number of Warrants	20,000
Weighted Average Remaining Life (in years)	3 months
Exercise Price | $ / shares	$ 1.50
Warrants outsanding 3 [Member]
Number of Warrants	708,666
Weighted Average Remaining Life (in years)	2 years 10 months 2 days
Exercise Price | $ / shares	$ 1.00
Warrants outsanding 2 [Member]
Number of Warrants	666,666
Weighted Average Remaining Life (in years)	2 years 10 months 2 days
Exercise Price | $ / shares	$ 0.50
Warrants outsanding 1 [Member]
Number of Warrants	349,998
Weighted Average Remaining Life (in years)	2 years 10 months 2 days
Exercise Price | $ / shares	$ 0.30
Warrants outsanding [Member]
Number of Warrants	100,000
Weighted Average Remaining Life (in years)	1 year 5 months 4 days
Exercise Price | $ / shares	$ 0.20

XML

Stockholders Equity (Details 2) - Stock option [Member]	3 Months Ended
	Sep. 30, 2021 $ / shares shares
Warrants shares, beginnig balance | shares	7,280,000
Warrants shares, ending balance | shares	7,280,000
Number of options, Exercisable | shares	6,170,000
Weighted Average Exercise Price
Weighted average exercise price, beginning	$ 0.23
Weighted Average Exercise Price, Granted	0
Weighted average exercise price, Ending	0.23
Weighted Average Exercise Price, Exercisable	$ 0.24
Weighted average remaining life, beginning	3 years 9 months 3 days
Weighted average remaining life, ending	3 years 6 months
Weighted average remaining life, exercisable	3 years 3 months 18 days

XML

Stockholders Equity (Details Narrative)	3 Months Ended
	Sep. 30, 2021 USD ($) shares
Common stock shares issued upon settlement of debt | shares	300,000
Common stock value issued upon settlement of debt	$ 30,000
Amount of debt settled	$ 30,000
Options [Member]
Number of warrants/rights outstanding | shares	7,280,000
Number of warrants/rights outstanding, intrisic value	$ 0
Share based compensation expense	73,994
Share based compensation expense, related parties	29,997
Share based compensation expense, unamortized	167,992
Share based compensation expense, unamortized, related parties	$ 79,995
Warrant [Member]
Number of warrants/rights outstanding | shares	2,563,996
Number of warrants/rights outstanding, intrisic value	$ 0

XML

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Debt conversion converted instrument, shares issued	30,000
Chief Executive Officer [Member] | June 11 2020 [Member]
Annual salary		$ 250,000
Salary				$ 180,000
Compensation expense	$ 62,500
Stratco Advisory and Tysadco Partners [Member] | August 1 2019 [Member] | Development service agreement [Member]
Service agreement description		the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash
Common stock, share amount		$ 0	$ 6,000
Debt conversion converted instrument, shares issued	300,000
Debt coversion, converted amount	$ 30,000
Accounts payable	$ 0	$ 30,000

XML

Subsequent Events (Details Narrative)	Sep. 30, 2020 USD ($) shares
Subsequent Events
Stock payable | $	$ 277,000
Common stock issued to settle Stock payable | shares	1,108,000